Inhibition of cdk2 kinase activity by methylselenocysteine in synchronized mouse mammary epithelial tumor cells

Carcinogenesis

Volumn 18, Issue 8, 1997, Pages 1541-1547

  Sinha, Raghu ^a   Medina, Daniel ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN E; PROTEIN KINASE; SELENITE; SELENOCYSTEINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME INHIBITION; EPITHELIUM TUMOR; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CDC2-CDC28 KINASES; CELL CYCLE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; CYCLINS; CYSTEINE; DNA; EPITHELIUM; MAMMARY GLANDS, ANIMAL; MICE; ORGANOSELENIUM COMPOUNDS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED;

EID: 0031418209     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.8.1541     Document Type: Article

References (33)

1. Ip, C., Hayes, C., Budnick, R.M. and Ganther, H.E. (1991) Chemical form of selenium, critical metabolites and cancer prevention. Cancer Res., 51, 595-600.
2. Ip, C. and Ganther, H.E. (1992) Relationship between the chemical form of selenium and anticarcinogenic activity. In Wattenberg, L., Lipkin, M., Boone, C.W. and Kellof, G.J. (eds), Cancer Chemoprevention. CRC Press, Boca Raton, FL, pp. 479-488.
3. Lu, J.X., Jiang, C., Kaeck, M., Ganther, H.E., Ip, C. and Thompson, H.J. (1995) Cellular and metabolic effects of triphenylselenonium chloride in a mammary cell culture model. Carcinogenesis, 16, 513-517.
4. Sinha, R., Said, T.K. and Medina, D. (1996) Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett., 107, 277-284.
5. King, R.W., Deshaies, R.J., Peters, J.-M. and Kirschner, M.W. (1996) How proteolysis drives the cell cycle. Science, 274, 1652-1658.
6. Sherr, C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
7. Stillman, B. (1996) Cell cycle control of DNA replication. Science, 274, 1659-1664.
8. Jerry, J.D., Butel, J.S. and Medina, D. (1994) p53 mutations in COMMA-D cells. In vitro Cell Dev. Biol., 30, 87-89.
9. Lowry, O.K. Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
10. Said, T.K. and Medina, D. (1995) Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development. Carcinogenesis, 161, 823-830.
11. Said, T.K., Luo, L. and Medina, D. (1995) Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to ckd4. Carcinogenesis, 16, 2507-2513.
12. Batist, G., Katki, A.G., Klecker, R.J. and Myers, C.E. (1986) Selenium-induced cytotoxicity of human leukemia cells: interaction with reduced glutathione. Cancer Res., 46, 5482-5485.
13. Jiang, X.R., Macey, M.G., Lin, H.X. and Newland, A.C. (1992) The anti-leukemic effects and the mechanism of sodium selenite. Leukemia Res., 16, 347-352.
14. Abdullaev, F.I., Macvicar, C. and Frenkel, G.D. (1992) Inhibition by selenium of DNA and RNA synthesis in normal and malignant human cells in vitro. Cancer Lett., 65, 43-49.
15. Vernie, L.N., Collard, J.G., Eker, A.P., De Wildt, A. and Wilders, I.T. (1979) Studies on the inhibition of protein synthesis by selenodiglutathione. Biochem. J., 180, 213-218.
16. Spyrou, G., Bjornstedt, M., Kumar, S. and Holmgren, A. (1995) AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione. FEBS Lett., 368, 59-63.
17. Tillotson, J.K., Upadhyaya, P. and Ronai, Z. (1994) Inhibition of thymidine kinase in cultured mammary tumor cells by the chemopreventive organoselenium compound, 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis, 15, 607-610.
18. Spyrou, G., Bjornstedt, M., Skog, S. and Holmgren, A. (1996) Selenite and selenate inhibit human lymphocyte growth via different mechanisms. Cancer Res., 56, 4407-4412.
19. Lanfear, J., Fleming, J., Wu, L., Webster, G. and Harrison, P.R. (1994) The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis, 15, 1387-1392.
20. Ohtsubo, M., Theodoras, A.M., Schumacher, J., Roberts, J.M. and Pagano, M. (1996) Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol., 15, 2612-2624.
21. Medina, D. and Oborn, C.J. (1981) Differential effects of selenium on the growth of mouse mammary cells in vitro. Cancer Lett., 13, 333-344.
22. Ip, C. and Ip, M.M. (1981) Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A. Carcinogenesis, 2, 915-918.
23. Chatterjee, M. and Banerjee, M.R. (1982) Selenium mediated dose inhibition of 7,12-dimethylbenzanthracene-induced transformation of mammary cells in organ culture. Cancer Lett., 17, 187-195.
24. Lu, J.X., Pei, H., Ip, C., Lisk, D.J., Ganther, H. and Thompson, H.J. (1996) Effect of an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis, 17, 1903-1907.
25. Cai, X.-J., Block, E., Uden, P.C., Zhang, X., Quimby, B.D. and Sullivan, J.J. (1995) Allium chemistry: identification of selenoamino acids in ordinary and selenium enriched garlic, onion and broccoli using gas chromatography with atomic emission detection. J. Agric. Fd Chem., 43, 1754-1757.
26. Chen, H.C. (1993) Inhibition of the protein kinase C-alpha gene overexpression in rat preneoplastic liver by selenium. Chines J. Oncol., 15, 279-281.
27. Chen, Z., Gundimeda, U. and Gopalakrishna, R. (1995) Selenium interacts with cysteine-rich regions of protein kinase C and induces the enzyme inactivation: its role in cancer chemoprevention. Proc. Am. Ass. Cancer Res., 36, 586.
28. Foiles, P.G., Fujiki, H., Sugaruma, M., Okabe, S., Yatsunami, J., Miglietta, L.M., Upadhyaya, P., El-Bayoumy, K. and Ronai, Z. (1995) Inhibition of PKC and PKA by chemopreventive organoselenium compounds. Int. J. Oncol., 7, 685-690.
29. Kawakami, K., Futami,H., Takahara, J. and Yamaguchi, K. (1996) UCN-01, 7-hydroxyl staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem. Biophys. Res. Commun., 219, 778-783.
30. Asiedu, C., Biggs, J., Lilly, M. and Kraft, S.A. (1995) Inhibition of leukemic cell growth by the protein kinase C activator Bryostatin 1 correlates with the dephosphorylation of cyclin-dependent kinase 2. Cancer Res., 55, 3716-3720.
31. Hamada, K., Takuwa, N., Zhou, W., Kumada, M. and Takuwa, Y. (1996) Protein kinase C inhibits the CAK-cdk2 cyclin dependent kinase cascade and G1/S cell cycle progression in human diploid fibroblasts. Biochim. Biophys. Acta, 1310, 149-156.
32. Thompson, H.J., Wilson, A., Lu, J.X., Singh, M., Jiang, C., Upadhyaya, P., El-Bayoumy, K. and Ip, C. (1994) Comparison of the effects of an organic and inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis, 15, 183-186.
33. Ronai, Z., Tillotson, J.K., Traganos, F., Darzynkiewicz, Z., Conaway, C.C., Upadhyaya, P. and El-Bayoumy, K. (1995) Effects of organic and inorganic selenium compounds on rat mammary tumor cells. Int. J. Cancer, 63, 428-134.